NCT01121731: A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C |
|
|
| Completed | 1/2 | 70 | Europe | Interferon α-5, Interferon-α5 plus Interferon-α 2b, Interferon α-2b (INTRON® A) | Digna Biotech S.L. | Chronic Hepatitis C Virus Infection, Genotype 1, Treatment-Experienced Patients, Relapses | 10/12 | 01/13 | | |
